Lupin receives FDA approval for generic Glumetza ER tabs
Is indicated as adjunct to diet and exercise to improve glycemic control in adults with type-2 diabetes mellitus
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Cipla India completes accquisition of Cipla Medpro SA
The acquisition aims to strengthen Cipla’s commitment to South Africa and the broader African continent
Novartis, Biological E sign agreement to protect against typhoid and paratyphoid fevers
License agreement advances a Novartis goal to deliver accessible and affordable vaccines that address unmet medical need in…
Venus gets GMP approval from Ukraine for nine manufacturing facilities
The recognition has opened more opportunities for Venus Remedies, to expand its product portfolio in the remaining Pharmaceutical…
MSD, Lupin announce strategic partnership
To co-market MSD's 23-valent pneumococcal polysaccharide vaccine for Indian market
Speakers at Nasal and Pulmonary Drug Delivery symposium to discuss global regulatory trends
Scheduled to present at the event, Dr Amit Misra, Scientist and Associate Professor AcSIR, CSIR-CDRI and Dr Julie Suman,…
Pharma Tech Expo 2013 to be held in Indore from Oct 6-8, 2013
Will be a great opportunity for machinery and equipment suppliers to showcase their products
IPM grows 4.8 per cent in June, valued at Rs 5899 crores
Nine therapies have outgrown the IPM growth
The Lanka Effect
Pharmaceutical companies from India are eager to increase their presence in the Sri Lankan market and both the countries have…
’HPV screening market seems to be growing in excess of 20 per cent annually’
IncellDx, an US-based molecular diagnostic company recently launched HPV Oncotect, a first of its kind molecular diagnostic test…